<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04934605</url>
  </required_header>
  <id_info>
    <org_study_id>2013-007</org_study_id>
    <nct_id>NCT04934605</nct_id>
  </id_info>
  <brief_title>Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA</brief_title>
  <official_title>A Genotype-phenotype Correlation of SLC26A4 Mutations in Cochlear-implanted Patients With Enlarged Vestibular Aqueduct</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted&#xD;
      patients with enlarged vestibular aqueduct.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Enlarged vestibular aqueduct (EVA) is one of the most common forms of inner ear malformation&#xD;
      that cause sensorineural hearing loss (SNHL). Some patients with EVA present delayed,&#xD;
      fluctuating, and progressive hearing loss, while the others are with congenital or sudden&#xD;
      hearing loss. Cochlear implants (CI) have been widely used in patients with severe-profound&#xD;
      SNHL. However, it is difficult to define the optimal timing of CI operations for patients&#xD;
      with EVA. Mutations in SLC26A4 are known to be responsible for EVA. This study is to explore&#xD;
      the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with&#xD;
      EVA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2010</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cochlear implant age</measure>
    <time_frame>Immediately after cochlear implantation</time_frame>
    <description>Age of cochlear implantation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of hearing loss</measure>
    <time_frame>Immediately after cochlear implantation</time_frame>
    <description>Time between found of hearing loss and cochlear implantation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Type of initial hearing loss</measure>
    <time_frame>On the 1 day of recruitment.</time_frame>
    <description>Prelingual or postlingual; Hearing aid can or cannot benefit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of hearing loss progression</measure>
    <time_frame>Immediately after cochlear implantation</time_frame>
    <description>Initial profound, sudden, or fluctuating hearing loss.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sensorineural Hearing Loss</condition>
  <condition>Enlarged Vestibular Aqueduct</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cochlear implantation</intervention_name>
    <description>Cochlear implantation</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with sensorineural hearing loss and enlarged vestibular aqueduct.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Bilateral severe-to-profound sensorineural hearing loss who received cochlear&#xD;
             implantation.&#xD;
&#xD;
          2. Bilateral or unilateral enlarged vestibular aqueduct (EVA) with or without Mondini&#xD;
             malformation (IP-II) on temporal bone computed tomography (CT) and/or magnetic&#xD;
             resonance imaging (MRI).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Hearing loss that is associated with symptoms which meet the criteria of already known&#xD;
             syndromes.&#xD;
&#xD;
          2. With other type of inner ear malformation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiao Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Otorhinolaryngology, 2nd Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2021</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>enlarged vestibular aqueduct</keyword>
  <keyword>SLC26A4</keyword>
  <keyword>cochlear implant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

